(MENAFN- Investor Brand Network) Shares of PerkinElmer Inc. (NYSE:PKI) traded today at $192.00, eclipsing its 52-week high. This new high was reached on approximately average trading volume as 633,000 shares traded hands, while the average 30-day volume is approximately 660,000 shares.
Based on a current price of $188.95, PerkinElmer Inc. is currently 39.5% above its average consensus analyst price target of $114.22.
PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes prenatal screening and infectious-disease testing, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening to environmental analytical tools.
In the past 52 weeks, PerkinElmer Inc. share prices are bracketed by a low of $116.27 and a high of $192.00 and is now at $188.95, 63% above that low price.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights , please visit
About IBN (InvestorBrandNetwork)
IBN consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years . Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and Code Editorial Syndication to 5,000+ broadcast outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series . With a proven track record serving 500+ client partners , IBN is the key to a more effective market communication campaign and the NEW normal.
For more information on IBN, please visit
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:
MENAFN23092021000224011066ID1102853849
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.